PASSPOINT PRO • CHAMBERLAIN
NR565
NR565 Final Practice Exam 2
100 Questions | GI + Complementary Therapies + Mixed
Clinical Prescribing
Original A-D multiple-choice practice • Compact PassPoint Pro layout • Detailed medication-safety
rationales
100 IMMEDIATE GI + CAM
Questions Rationales Focus
Original study and revision material • Clean print-ready format
,PASSPOINT PRO | NR565 ADVANCED PHARMACOLOGY FUNDAMENTALS
NR565 Final Practice Exam 2
100 Questions | GI + Complementary Therapies + Mixed Clinical Prescribing
Directions: Select the single best answer. Focus on the safest prescribing decision for the individual patient. Unless a question
states otherwise, assume standard adult dosing principles and that all relevant clinical information has been provided.
1. A patient seen in primary care is being managed in primary care. a patient taking H. pylori eradication
therapy calls the clinic. Which possible medication-related problem is most consistent with this therapy?
A. headache and, especially with renal impairment or older age, confusion can occur
B. acute dystonia, akathisia, and tardive dyskinesia with cumulative exposure
C. headache and diarrhea; prolonged use is associated with risks such as hypomagnesemia, B12 deficiency, enteric infection,
and fractures in susceptible patients
D. GI upset and regimen-specific antibiotic adverse effects
Answer: D
Explanation: The major safety issue to remember is GI upset and regimen-specific antibiotic adverse effects. This matters because
medication selection in NR565-style scenarios depends on matching the drug to the patient's comorbidities, concurrent therapies,
and monitoring plan. The safest answer is therefore the option that aligns with the known pharmacology and prescribing precautions
of H. pylori eradication therapy.
2. A patient returning for medication follow-up is being managed in primary care. the NP is completing
medication reconciliation for a patient using echinacea. Which counseling point should be reinforced?
A. tell clinicians before procedures and if taking anticoagulants or antiplatelet drugs
B. take at a time matched to the sleep goal and use caution with driving if drowsy
C. do not assume it replaces vaccination or evidence-based treatment and disclose use with immunosuppressive therapy
D. tell every prescriber/pharmacist before use because it can reduce effectiveness of many prescription drugs
Answer: C
Explanation: A high-yield counseling point is to do not assume it replaces vaccination or evidence-based treatment and disclose use
with immunosuppressive therapy. This matters because medication selection in NR565-style scenarios depends on matching the
drug to the patient's comorbidities, concurrent therapies, and monitoring plan. The safest answer is therefore the option that aligns
with the known pharmacology and prescribing precautions of echinacea.
3. A patient is being evaluated for medication therapy. Which clinical use best matches empagliflozin?
A. controller therapy for persistent asthma
B. type 2 diabetes, especially when cardiovascular or kidney benefits are desirable in an appropriate patient
C. short-term relief of acid-related dyspepsia or heartburn
D. most nonpregnant adults requiring antithyroid drug therapy for hyperthyroidism
Answer: B
Explanation: Empagliflozin is a SGLT2 inhibitor used for type 2 diabetes, especially when cardiovascular or kidney benefits are
desirable in an appropriate patient. This matters because medication selection in NR565-style scenarios depends on matching the
drug to the patient's comorbidities, concurrent therapies, and monitoring plan. The safest answer is therefore the option that aligns
with the known pharmacology and prescribing precautions of empagliflozin.
4. Which statement best describes the primary pharmacologic action of alendronate?
A. provides synthetic thyroxine that is converted to active T3 in tissues
B. inhibits osteoclast-mediated bone resorption
C. replaces cortisol activity needed for vascular tone, metabolism, and stress response
D. reduces hepatic glucose production and improves insulin sensitivity
Answer: B
Explanation: Its key action is that it inhibits osteoclast-mediated bone resorption. This matters because medication selection in
NR565-style scenarios depends on matching the drug to the patient's comorbidities, concurrent therapies, and monitoring plan. The
safest answer is therefore the option that aligns with the known pharmacology and prescribing precautions of alendronate.
5. Which adverse-effect profile is most important for the prescriber to recognize with salmeterol?
A. injection-site reactions and rare anaphylaxis
B. neuropsychiatric reactions can occur, including mood or behavior changes
C. tremor, tachycardia, and paradoxical bronchospasm
D. weight loss, diarrhea, insomnia, and neuropsychiatric symptoms
Answer: C
Explanation: The major safety issue to remember is tremor, tachycardia, and paradoxical bronchospasm. This matters because
medication selection in NR565-style scenarios depends on matching the drug to the patient's comorbidities, concurrent therapies,
and monitoring plan. The safest answer is therefore the option that aligns with the known pharmacology and prescribing precautions
of salmeterol.
6. A 35-year-old patient is being managed in primary care. a patient starts omalizumab. Which monitoring
plan is most appropriate for safe follow-up?
A. clinical response, glucose in at-risk patients, and adverse effects
B. bronchodilator response and anticholinergic symptoms
C. breathing symptoms and anticholinergic adverse effects
Original practice material for study and review Page56
Page 2
, PASSPOINT PRO | NR565 ADVANCED PHARMACOLOGY FUNDAMENTALS
D. clinical response and signs of anaphylaxis after administration according to protocol
Answer: D
Explanation: Appropriate follow-up includes clinical response and signs of anaphylaxis after administration according to protocol.
This matters because medication selection in NR565-style scenarios depends on matching the drug to the patient's comorbidities,
concurrent therapies, and monitoring plan. The safest answer is therefore the option that aligns with the known pharmacology and
prescribing precautions of omalizumab.
7. Which patient-teaching statement is most appropriate for a new prescription of aluminum/magnesium
antacid?
A. separate from many prescription medicines by at least a couple of hours as directed
B. take on an empty stomach and separate from many other medications because it can reduce their absorption
C. use consistently even when symptoms improve and report reduced urine output or unexplained swelling
D. report fever or infection symptoms and avoid live vaccines during significant immunosuppression
Answer: A
Explanation: A high-yield counseling point is to separate from many prescription medicines by at least a couple of hours as directed.
This matters because medication selection in NR565-style scenarios depends on matching the drug to the patient's comorbidities,
concurrent therapies, and monitoring plan. The safest answer is therefore the option that aligns with the known pharmacology and
prescribing precautions of aluminum/magnesium antacid.
8. A patient preparing for discharge is being managed in primary care. which situation should make the
prescriber avoid or use particular caution with infliximab?
A. suspected bowel obstruction or acute surgical abdomen
B. active serious infection
C. unmonitored use in significant renal disease
D. choosing a regimen without considering prior macrolide exposure, local resistance, allergies, and interactions
Answer: B
Explanation: Prescribers should avoid or use special caution with infliximab in active serious infection. This matters because
medication selection in NR565-style scenarios depends on matching the drug to the patient's comorbidities, concurrent therapies,
and monitoring plan. The safest answer is therefore the option that aligns with the known pharmacology and prescribing precautions
of infliximab.
9. Which interaction or coadministration issue is most relevant to valerian?
A. may alter warfarin effect and can contribute to hypoglycemia with glucose-lowering therapy
B. additive CNS depression with alcohol, benzodiazepines, opioids, and sedating antihistamines
C. theoretical or variable interactions with immunosuppressants and CYP-metabolized drugs
D. alcohol, benzodiazepines, opioids, and sedating antihistamines can increase CNS depression
Answer: D
Explanation: A clinically important interaction is that alcohol, benzodiazepines, opioids, and sedating antihistamines can increase
CNS depression. This matters because medication selection in NR565-style scenarios depends on matching the drug to the patient's
comorbidities, concurrent therapies, and monitoring plan. The safest answer is therefore the option that aligns with the known
pharmacology and prescribing precautions of valerian.
10. A 48-year-old adult is being managed in primary care. at a follow-up visit after starting semaglutide,
which information should receive the highest priority when evaluating efficacy and safety?
A. fasting glucose trends and episodes of hypoglycemia
B. A1C/glucose, weight, hydration, and persistent severe abdominal symptoms
C. glucose, blood pressure, infection signs, and need for taper after prolonged courses
D. TSH (and free T4 when indicated) after dose changes and periodically once stable
Answer: B
Explanation: Appropriate follow-up includes A1C/glucose, weight, hydration, and persistent severe abdominal symptoms. This
matters because medication selection in NR565-style scenarios depends on matching the drug to the patient's comorbidities,
concurrent therapies, and monitoring plan. The safest answer is therefore the option that aligns with the known pharmacology and
prescribing precautions of semaglutide.
11. A 35-year-old patient is being managed in primary care. a patient taking hydrocortisone replacement
calls the clinic. Which possible medication-related problem is most consistent with this therapy?
A. gastrointestinal upset; rare lactic acidosis risk rises with severe renal dysfunction or hypoxia
B. nausea and vomiting; response may be reduced when glycogen stores are depleted
C. hypoglycemia and weight gain
D. over-replacement can cause weight gain, hypertension, hyperglycemia, and osteoporosis
Answer: D
Explanation: The major safety issue to remember is over-replacement can cause weight gain, hypertension, hyperglycemia, and
osteoporosis. This matters because medication selection in NR565-style scenarios depends on matching the drug to the patient's
comorbidities, concurrent therapies, and monitoring plan. The safest answer is therefore the option that aligns with the known
pharmacology and prescribing precautions of hydrocortisone replacement.
12. A patient returning for medication follow-up is being managed in primary care. the NP is completing
medication reconciliation for a patient using fluticasone/salmeterol. Which counseling point should be
reinforced?
Original practice material for study and review Page57
Page 3
NR565
NR565 Final Practice Exam 2
100 Questions | GI + Complementary Therapies + Mixed
Clinical Prescribing
Original A-D multiple-choice practice • Compact PassPoint Pro layout • Detailed medication-safety
rationales
100 IMMEDIATE GI + CAM
Questions Rationales Focus
Original study and revision material • Clean print-ready format
,PASSPOINT PRO | NR565 ADVANCED PHARMACOLOGY FUNDAMENTALS
NR565 Final Practice Exam 2
100 Questions | GI + Complementary Therapies + Mixed Clinical Prescribing
Directions: Select the single best answer. Focus on the safest prescribing decision for the individual patient. Unless a question
states otherwise, assume standard adult dosing principles and that all relevant clinical information has been provided.
1. A patient seen in primary care is being managed in primary care. a patient taking H. pylori eradication
therapy calls the clinic. Which possible medication-related problem is most consistent with this therapy?
A. headache and, especially with renal impairment or older age, confusion can occur
B. acute dystonia, akathisia, and tardive dyskinesia with cumulative exposure
C. headache and diarrhea; prolonged use is associated with risks such as hypomagnesemia, B12 deficiency, enteric infection,
and fractures in susceptible patients
D. GI upset and regimen-specific antibiotic adverse effects
Answer: D
Explanation: The major safety issue to remember is GI upset and regimen-specific antibiotic adverse effects. This matters because
medication selection in NR565-style scenarios depends on matching the drug to the patient's comorbidities, concurrent therapies,
and monitoring plan. The safest answer is therefore the option that aligns with the known pharmacology and prescribing precautions
of H. pylori eradication therapy.
2. A patient returning for medication follow-up is being managed in primary care. the NP is completing
medication reconciliation for a patient using echinacea. Which counseling point should be reinforced?
A. tell clinicians before procedures and if taking anticoagulants or antiplatelet drugs
B. take at a time matched to the sleep goal and use caution with driving if drowsy
C. do not assume it replaces vaccination or evidence-based treatment and disclose use with immunosuppressive therapy
D. tell every prescriber/pharmacist before use because it can reduce effectiveness of many prescription drugs
Answer: C
Explanation: A high-yield counseling point is to do not assume it replaces vaccination or evidence-based treatment and disclose use
with immunosuppressive therapy. This matters because medication selection in NR565-style scenarios depends on matching the
drug to the patient's comorbidities, concurrent therapies, and monitoring plan. The safest answer is therefore the option that aligns
with the known pharmacology and prescribing precautions of echinacea.
3. A patient is being evaluated for medication therapy. Which clinical use best matches empagliflozin?
A. controller therapy for persistent asthma
B. type 2 diabetes, especially when cardiovascular or kidney benefits are desirable in an appropriate patient
C. short-term relief of acid-related dyspepsia or heartburn
D. most nonpregnant adults requiring antithyroid drug therapy for hyperthyroidism
Answer: B
Explanation: Empagliflozin is a SGLT2 inhibitor used for type 2 diabetes, especially when cardiovascular or kidney benefits are
desirable in an appropriate patient. This matters because medication selection in NR565-style scenarios depends on matching the
drug to the patient's comorbidities, concurrent therapies, and monitoring plan. The safest answer is therefore the option that aligns
with the known pharmacology and prescribing precautions of empagliflozin.
4. Which statement best describes the primary pharmacologic action of alendronate?
A. provides synthetic thyroxine that is converted to active T3 in tissues
B. inhibits osteoclast-mediated bone resorption
C. replaces cortisol activity needed for vascular tone, metabolism, and stress response
D. reduces hepatic glucose production and improves insulin sensitivity
Answer: B
Explanation: Its key action is that it inhibits osteoclast-mediated bone resorption. This matters because medication selection in
NR565-style scenarios depends on matching the drug to the patient's comorbidities, concurrent therapies, and monitoring plan. The
safest answer is therefore the option that aligns with the known pharmacology and prescribing precautions of alendronate.
5. Which adverse-effect profile is most important for the prescriber to recognize with salmeterol?
A. injection-site reactions and rare anaphylaxis
B. neuropsychiatric reactions can occur, including mood or behavior changes
C. tremor, tachycardia, and paradoxical bronchospasm
D. weight loss, diarrhea, insomnia, and neuropsychiatric symptoms
Answer: C
Explanation: The major safety issue to remember is tremor, tachycardia, and paradoxical bronchospasm. This matters because
medication selection in NR565-style scenarios depends on matching the drug to the patient's comorbidities, concurrent therapies,
and monitoring plan. The safest answer is therefore the option that aligns with the known pharmacology and prescribing precautions
of salmeterol.
6. A 35-year-old patient is being managed in primary care. a patient starts omalizumab. Which monitoring
plan is most appropriate for safe follow-up?
A. clinical response, glucose in at-risk patients, and adverse effects
B. bronchodilator response and anticholinergic symptoms
C. breathing symptoms and anticholinergic adverse effects
Original practice material for study and review Page56
Page 2
, PASSPOINT PRO | NR565 ADVANCED PHARMACOLOGY FUNDAMENTALS
D. clinical response and signs of anaphylaxis after administration according to protocol
Answer: D
Explanation: Appropriate follow-up includes clinical response and signs of anaphylaxis after administration according to protocol.
This matters because medication selection in NR565-style scenarios depends on matching the drug to the patient's comorbidities,
concurrent therapies, and monitoring plan. The safest answer is therefore the option that aligns with the known pharmacology and
prescribing precautions of omalizumab.
7. Which patient-teaching statement is most appropriate for a new prescription of aluminum/magnesium
antacid?
A. separate from many prescription medicines by at least a couple of hours as directed
B. take on an empty stomach and separate from many other medications because it can reduce their absorption
C. use consistently even when symptoms improve and report reduced urine output or unexplained swelling
D. report fever or infection symptoms and avoid live vaccines during significant immunosuppression
Answer: A
Explanation: A high-yield counseling point is to separate from many prescription medicines by at least a couple of hours as directed.
This matters because medication selection in NR565-style scenarios depends on matching the drug to the patient's comorbidities,
concurrent therapies, and monitoring plan. The safest answer is therefore the option that aligns with the known pharmacology and
prescribing precautions of aluminum/magnesium antacid.
8. A patient preparing for discharge is being managed in primary care. which situation should make the
prescriber avoid or use particular caution with infliximab?
A. suspected bowel obstruction or acute surgical abdomen
B. active serious infection
C. unmonitored use in significant renal disease
D. choosing a regimen without considering prior macrolide exposure, local resistance, allergies, and interactions
Answer: B
Explanation: Prescribers should avoid or use special caution with infliximab in active serious infection. This matters because
medication selection in NR565-style scenarios depends on matching the drug to the patient's comorbidities, concurrent therapies,
and monitoring plan. The safest answer is therefore the option that aligns with the known pharmacology and prescribing precautions
of infliximab.
9. Which interaction or coadministration issue is most relevant to valerian?
A. may alter warfarin effect and can contribute to hypoglycemia with glucose-lowering therapy
B. additive CNS depression with alcohol, benzodiazepines, opioids, and sedating antihistamines
C. theoretical or variable interactions with immunosuppressants and CYP-metabolized drugs
D. alcohol, benzodiazepines, opioids, and sedating antihistamines can increase CNS depression
Answer: D
Explanation: A clinically important interaction is that alcohol, benzodiazepines, opioids, and sedating antihistamines can increase
CNS depression. This matters because medication selection in NR565-style scenarios depends on matching the drug to the patient's
comorbidities, concurrent therapies, and monitoring plan. The safest answer is therefore the option that aligns with the known
pharmacology and prescribing precautions of valerian.
10. A 48-year-old adult is being managed in primary care. at a follow-up visit after starting semaglutide,
which information should receive the highest priority when evaluating efficacy and safety?
A. fasting glucose trends and episodes of hypoglycemia
B. A1C/glucose, weight, hydration, and persistent severe abdominal symptoms
C. glucose, blood pressure, infection signs, and need for taper after prolonged courses
D. TSH (and free T4 when indicated) after dose changes and periodically once stable
Answer: B
Explanation: Appropriate follow-up includes A1C/glucose, weight, hydration, and persistent severe abdominal symptoms. This
matters because medication selection in NR565-style scenarios depends on matching the drug to the patient's comorbidities,
concurrent therapies, and monitoring plan. The safest answer is therefore the option that aligns with the known pharmacology and
prescribing precautions of semaglutide.
11. A 35-year-old patient is being managed in primary care. a patient taking hydrocortisone replacement
calls the clinic. Which possible medication-related problem is most consistent with this therapy?
A. gastrointestinal upset; rare lactic acidosis risk rises with severe renal dysfunction or hypoxia
B. nausea and vomiting; response may be reduced when glycogen stores are depleted
C. hypoglycemia and weight gain
D. over-replacement can cause weight gain, hypertension, hyperglycemia, and osteoporosis
Answer: D
Explanation: The major safety issue to remember is over-replacement can cause weight gain, hypertension, hyperglycemia, and
osteoporosis. This matters because medication selection in NR565-style scenarios depends on matching the drug to the patient's
comorbidities, concurrent therapies, and monitoring plan. The safest answer is therefore the option that aligns with the known
pharmacology and prescribing precautions of hydrocortisone replacement.
12. A patient returning for medication follow-up is being managed in primary care. the NP is completing
medication reconciliation for a patient using fluticasone/salmeterol. Which counseling point should be
reinforced?
Original practice material for study and review Page57
Page 3
